Please login to the form below

Not currently logged in
Email:
Password:

ticagrelor

This page shows the latest ticagrelor news and features for those working in and with pharma, biotech and healthcare.

Better times ahead, promises AZ as Crestor drop outweighs new drugs

Better times ahead, promises AZ as Crestor drop outweighs new drugs

Among the company’s other growth products, antiplatelet drug Brilinta (ticagrelor) continued to perform as expected with a 24% sales increase to $293m.

Latest news

More from news
Approximately 6 fully matching, plus 41 partially matching documents found.

Latest appointments

  • AZ names Brilique lead in Spain AZ names Brilique lead in Spain

    In this role Gribble will be responsible for the company's marketing of Brilique (ticagrelor) for acute coronary syndrome, including management, development and market access activities, and he will also be

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Quintiles Medical Communications

Quintiles’ award-winning medical communications group sits at the heart of the enterprise. We offer a range of innovative strategic services,...

Latest intelligence

Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...
Light_bulb_Stock_Market.jpg
Creativity has lost its worth
Creativity has lost its worth, and sadly it is undermining effectiveness...

Infographics